β-Elemene enhances susceptibility to cisplatin in resistant ovarian carcinoma cells via downregulation of ERCC-1 and XIAP and inactivation of JNK. [electronic resource]
Producer: 20140407Description: 721-8 p. digitalISSN:- 1791-2423
- Apoptosis -- drug effects
- Carcinoma -- drug therapy
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Cisplatin -- administration & dosage
- DNA-Binding Proteins -- biosynthesis
- Down-Regulation -- drug effects
- Drug Resistance, Neoplasm -- drug effects
- Endonucleases -- biosynthesis
- Female
- Gene Expression Regulation, Neoplastic -- drug effects
- Humans
- JNK Mitogen-Activated Protein Kinases -- biosynthesis
- Ovarian Neoplasms -- drug therapy
- Sesquiterpenes -- administration & dosage
- X-Linked Inhibitor of Apoptosis Protein -- biosynthesis
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.